CFGS
DXCM icon

Concourse Financial Group Securities’s DexCom DXCM Stock Holding History

Concourse Financial Group Securities’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,695
Closed -$496K – 554
2024
Q4 		$496K Buy
5,695
+116
+2% +$8.59K 0.03% 480
2024
Q3 		$374K Sell
5,579
-2,148
-28% -$176K 0.02% 530
2024
Q2 		$876K Sell
7,727
-1,327
-15% -$168K 0.05% 325
2024
Q1 		$1.26M Sell
9,054
-595
-6% -$74.8K 0.08% 243
2023
Q4 		$1.2M Buy
9,649
+496
+5% +$50.7K 0.09% 244
2023
Q3 		$854K Buy
9,153
+730
+9% +$82.3K 0.07% 291
2023
Q2 		$1.08M Sell
8,423
-309
-4% -$37.4K 0.08% 244
2023
Q1 		$1.01M Sell
8,732
-326
-4% -$36.5K 0.08% 259
2022
Q4 		$1.03M Sell
9,058
-1,419
-14% -$156K 0.08% 249
2022
Q3 		$844K Sell
10,477
-701
-6% -$59.4K 0.08% 249
2022
Q2 		$833K Sell
11,178
-146
-1% -$13.3K 0.07% 283
2022
Q1 		$1.45M Sell
11,324
-7,136
-39% -$781K 0.11% 194
2021
Q4 		$2.48M Buy
18,460
+412
+2% +$59.2K 0.14% 137
2021
Q3 		$2.47M Buy
18,048
+472
+3% +$59.5K 0.15% 131
2021
Q2 		$1.88M Buy
17,576
+1,324
+8% +$127K 0.12% 157
2021
Q1 		$1.46M Buy
16,252
+5,248
+48% +$493K 0.1% 178
2020
Q4 		$1.02M Buy
11,004
+2,356
+27% +$210K 0.08% 227
2020
Q3 		$891K Buy
8,648
+2,040
+31% +$213K 0.08% 217
2020
Q2 		$670K Buy
6,608
+2,228
+51% +$199K 0.07% 244
2020
Q1 		$295K Buy
4,380
+1,264
+41% +$78.7K 0.03% 368
2019
Q4 		$170K Buy
3,116
+1,348
+76% +$63.9K 0.02% 540
2019
Q3 		$66K Buy
1,768
+1,628
+1,163% +$63.2K 0.02% 536
2019
Q2 		$5K Hold
140
– – ﹤0.01% 1717
2019
Q1 		$4K Buy
+140
New +$4.92K ﹤0.01% 1795

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Concourse Financial Group Securities's DXCM Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of DexCom (DXCM) in Q1 2025, closing a stake of 5,695 shares — an estimated $496K sold.

Concourse Financial Group Securities first reported a position in DXCM in Q1 2019 and held it in 24 quarters. The position peaked at $2.48M in Q4 2021. 933 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 5,695 DexCom shares in Q1 2025, an estimated $496K.
  • Concourse Financial Group Securities first reported a position in DexCom in Q1 2019 and held it in 24 quarters.
  • Concourse Financial Group Securities's DexCom position peaked at $2.48M in Q4 2021.
  • 933 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.